SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,388,330 | -3.7% | 93,329 | -14.1% | 0.02% | -12.0% |
Q1 2023 | $4,557,779 | +3.3% | 108,622 | -6.1% | 0.02% | 0.0% |
Q4 2022 | $4,411,463 | +90.3% | 115,665 | +95.4% | 0.02% | +66.7% |
Q3 2022 | $2,318,000 | +33.8% | 59,183 | +10.3% | 0.02% | +36.4% |
Q2 2022 | $1,733,000 | +23.2% | 53,643 | +26.2% | 0.01% | +57.1% |
Q1 2022 | $1,407,000 | -54.9% | 42,503 | -42.1% | 0.01% | -53.3% |
Q4 2021 | $3,121,000 | +30.9% | 73,377 | +36.3% | 0.02% | +25.0% |
Q3 2021 | $2,385,000 | +200.8% | 53,833 | +408.1% | 0.01% | +200.0% |
Q1 2021 | $793,000 | +95.3% | 10,596 | +125.8% | 0.00% | +100.0% |
Q4 2020 | $406,000 | – | 4,692 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |